Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)

ClinicalTrials.gov ID: NCT00308139

Public ClinicalTrials.gov record NCT00308139. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-Label, Multicenter, Comparator-Controlled Study to Examine the Effects of Exenatide Long-Acting Release on Glucose Control (HbA1c) and Safety in Subjects With Type 2 Diabetes Mellitus Managed With Diet Modification and Exercise and/or Oral Antidiabetic Medications

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Randomized, Open-Label, Multicenter, Comparator-Controlled Study to Examine the Effects of Exenatide Long-Acting Release (LAR) on Glucose Control (HbA1c) and Safety in Subjects with Type 2 Diabetes Mellitus Managed with Diet Modification and Exercise and/or Oral Antidiabetic Medications.

Study identification

NCT ID
NCT00308139
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
303 participants

Conditions and interventions

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2006 (Type not available)
Primary completion
Jul 2008 (Actual)
Completion
Aug 2014 (Actual)
Last update posted
Aug 26, 2015

2006 – 2014

United States locations

U.S. sites
24
U.S. states
18
U.S. cities
24
Facility City State ZIP Site status
Research Site 182 Encino California 91436 —
Research Site 171 La Jolla California 92037 —
Research Site 518 San Diego California 92161 —
Research Site 024 Walnut Creek California 94598 —
Research Site Colorado Springs Colorado — —
Research Site 057 Miami Florida 33156 —
Research Site Chicago Illinois — —
Research Site 149 Indianapolis Indiana 46254 —
Research Site 099 Lexington Kentucky 40503 —
Research Site 017 Detroit Michigan 48202 —
Research Site 224 Minneapolis Minnesota 55416 —
Research Site 312 St Louis Missouri 63141 —
Research Site 023 Butte Montana 59701 —
Research Site 053 Rochester New York 14609 —
Research Site 002 Durham North Carolina 27713 —
Research Site 123 Winston-Salem North Carolina 27103 —
Research Site 405 Cincinnati Ohio 45219 —
Research Site 557 Marion Ohio 43302 —
Research Site 231 Portland Oregon 97239 —
Research Site 152 Philadelphia Pennsylvania 19146 —
Research Site 587 Greer South Carolina 29651 —
Research Site 015 Dallas Texas 75230 —
Research Site 009 San Antonio Texas 78229 —
Research Site 108 Olympia Washington 98502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00308139, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2015 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00308139 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →